reported that intravenous glutamine supplementation at doses of 0.30.5 g/kg per day in critically ill patients was associated with significant reductions in hospital mortality, treatment duration, and infectious complications
Medications such as semaglutide, best known under the brand name Ozempic, have transformed the treatment of obesity and metabolic disease
Sato R, von Haehling S (2024) Targeting obesity for therapeutic intervention in heart failure patients
Products like Pepto-Bismol or Kaopectate may help with general gastric discomfort, while Dramamine can be useful for nausea or dizziness
These trends reflect a broader shift in menopause care driven by evolving clinical evidence, increased public awareness, and recent regulatory changes, including the removal of longstanding FDA boxed warnings
Dosages and prices may change based on individual results to ensure you receive the most effective treatment